The European Medicines Agency emphasizes that the benefits of the jab in protecting against COVID-19 still far outweigh the risks.

One hundred years after its invention, BCG has stood the test of time as a vaccine against tuberculosis.

Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.

Johnson & Johnson’s one-shot immunization could reach people’s arms as early as March 2.

In a triumph for science, COVID-19 statistics are finally trending favorably in the US. We must make sure the rest of the world is not left behind.

Geeta Swamy of Duke University School of Medicine speaks with The Scientist about starting what she considers a long-overdue clinical study of COVID-19 vaccines in pregnant women.

Two preliminary reports from the UK provide real-world evidence in support of the Pfizer/BioNTech and Oxford-AstraZeneca vaccines.

A case study finds SARS-CoV-2 antibodies in placental cord blood after maternal vaccination.

Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.